Skip to main content
SpringerLink
Log in

Effects on Pharmaceuticals in the Environment — an Overview and Principle Considerations

  • Chapter
Pharmaceuticals in the Environment

Abstract

For the 2 684 and more than 3 000 pharmaceutical compounds registered in Germany (Rote Liste 2000) and Great Britain (Ayscough et al. 2000), respectively, the predominant proportion of the available information is characterised by data from preclinical and clinical studies. These data and respective peer- and non-peer reviewed literature can either be retrieved from the pharmaceutical companies themselves or in a more concentrated fashion from on-line databases, e.g. Toxnet (http://www.sis.nlm.nih.gov/ToxSearch.cfm), which includes information from databases such as HSDB, Genetox, Toxline etc., and from literature databases, e.g. MedLine, Biosis and Embase. Little information can be found, however, on the fate, transport and effects of these pharmaceuticals once they have been released into the environment (direct disposal and/or indirect disposal via sewage treatment plants, STPs). This paucity of data raises several questions: do the pharmaceuticals reach the environment and in what quantity? What are the known and potential acute, subchronic and chronic adverse effects of these compounds in exposed environmental species and the ecosystem as a whole?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andrade-Mena CE (1996) Immunodepression induced by carbamazepine administration is mediated by CD 8 spleen T cells. Int J Tissue React 18 (2–3): 81–85

    CAS  Google Scholar 

  • Andrade-Mena CE, Sardo-Olmedo JA, Ramirez-Lizardo EJ (1994) Effects of carbamazepine on murine humoral and cellular immune responses. Epilepsia 35 (1): 205–208

    Article  CAS  Google Scholar 

  • ASTM (1991) Standard guide for conducting the frog embryo teratogenesis assay-Xenopus (FETAX). E 1439–91. American Society for Testing and Materials, Philadelphia, USA, pp 1–11

    Google Scholar 

  • Ayscough NJ, Fawell J, Franklin G, Young W (2000) Review of human pharmaceuticals in the environment. Environment Agency, Bristol (Technical report P39o)

    Google Scholar 

  • Dietrich D, Knoll S, Schmid T, Rumpf S (1998a) Literaturrecherche zum Zusammenhang von Umweltschadstoffen und Schädigungen von Salmoniden im Liechtensteiner-,Werdenberger-und RheintalerBinnenkanal. Amt für Umweltschutz, St Gallen, Schweiz

    Google Scholar 

  • Dietrich D, Schreiber H, Rumpf S (1998b) Literaturrecherche zu Pharmaka im aquatischen Milieu. Environmental Toxicology, University of Konstanz, Konstanz

    Google Scholar 

  • Dietrich DR, Prietz A (1999) Fish embryotoxicity and teratogenicity of pharmaceuticals, detergents and pes- ticides regularly detected in sewage treatment plant effluents and surface waters. Toxicol Sci 48 (1-S): 151

    Google Scholar 

  • Dietrich DR, Prietz A, Kiamos MA (1998c) Danio renio embryotoxicity and teratogenicity assay (DRETA) for detecting waterborne embryo-toxicants and teratogens. Toxicol Sci 42(1-S):259

    Google Scholar 

  • Garrison AW, Pope JD, Allen FR (1976) GC/MS analysis of organic compounds in domestic wastewaters. In: Keith CH (ed) Identification and analysis of organic pollutants in water. AnnArbor Science,Ann Arbor

    Google Scholar 

  • Garzon P, Gonzalez-Cornejo S, Hernandez-Hernandez G, Aguirre-Portillo L, Almodovar-Cuevas C, Navarro-Ruiz A (1986) Effects of antiepileptic drugs on concentration of serum proteins and immunoglobulins of epileptic patients. Gen Pharmaco117(1): 49–55

    Google Scholar 

  • Halling-Sorensen B, Nielsen SN, Lanzky PF, Ingerslev F, Lützohft HCH, Jorgensen SE (1998) Occurrence,fate and effects of pharmaceutical substances in the environment. A review. Chemosphere 36 (2): 357–393

    Article  CAS  Google Scholar 

  • Hartmann A, Alder AC, Koller T, Widmer RM (1998) Identification of fluoroquinone antibiotics as the main source of umu-C genotoxicity in native hospital wastewater. Environ Toxicol Chem 17 (3): 377–382

    CAS  Google Scholar 

  • Heberer T, Stan HJ (1996) Vorkommen von polaren organischen Kontaminanten im Berliner Trinkwasser. Vom Wasser 86: 19–31

    CAS  Google Scholar 

  • Heberer T, Dünnbier U, Reilich C, Stan HJ (1997) Detection of drugs and drug metabolites in ground water samples of a drinking water treatment plant. Fresenius Environ Bull 6: 438–443

    CAS  Google Scholar 

  • Heberer T, Schmidt-Baumler K, Stan HJ (1998) Occurrence and distribution of organic contaminants in the aquatic system in Berlin. Part I: Drug residues and other polar contaminants in Berlin surface and groundwater. Acta Hydroch Hydrob 26: 272–278

    Google Scholar 

  • Henschel KP, Wenzel A, Diedrich M, Fliedner A (1997) Environmental hazard assessment of pharmaceuticals. Regul Toxicol Pharmacol 25 (3): 220–225

    Article  CAS  Google Scholar 

  • Hignite C, Azarnoff DL (1977) Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicylic acid in sewage water effluent. Life Sci 20 (2): 337–341

    Article  CAS  Google Scholar 

  • Hirsch R, Ternes TA, Haberer K, Kratz KL (1999) Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225 09–118

    Article  Google Scholar 

  • Lunden T, Miettinen S, Lonnstrom LG, Lilius EM, Bylund G (1998) Influence of oxytetracycline and oxolinic acid on the immune response of rainbow trout (Oncorhynchus mykiss). Fish and Shellfish Immunol 8 (3): 217–230

    Article  Google Scholar 

  • Lunden T, Miettinen S, Lonnstrom LG, Lilius EM, Bylund G (1999) Effect of florfenicol on the immune response of rainbow trout (Oncorhynchus mykiss). Vet Immunol Immunopathol 67 (4): 317–25

    Article  CAS  Google Scholar 

  • McLachlan JA (1980) Estrogens in the environment. Elsevier, New York

    Google Scholar 

  • McLachlan JA (1985) Estrogens in the environment II. Influences on development. Elsevier, New York McLachlan JA (1993) Functional toxicology: a new approach to detect biologically active xenobiotics. Environ Health Perspect 101: 386–387

    Article  Google Scholar 

  • McLachlan JA, Korach KS (1995) Symposium on estrogens in the environment III: Global health implications. Environ Health Perspect 1o3(Suppl 7 ): 3–178

    Article  Google Scholar 

  • McLachlan JA, Newbold RR (1987) Estrogens and development. Environ Health Perspect 75: 25–27

    Article  CAS  Google Scholar 

  • Mcachlan JA, Korach KS, Newbold RR, Degen GH (1984) Diethylstilbestrol and other estrogens in the environment. Fundam Appl Toxicol 4: 686–691

    Article  Google Scholar 

  • McLachlan JA, Pratt RM,Markert CL (1987) Developmental toxicology: mechanisms and risk. Cold Spring Harbor Laboratory, Cold Spring Harbor (Banbury Report )

    Google Scholar 

  • Moffitt CM (1991) Oral and injectable applications of erythromycin in salmonid fish culture. Vet Hum Toxico133(Suppl 1 ): 49–53

    Google Scholar 

  • Moffitt CM (1998) Field trials of investigational new animal drugs. Vet Hum Toxicol 4o (Suppl 2): 48–52

    Google Scholar 

  • OECD (1984a) Alga, Growth inhibition test. OECD Guidelines For Testing of Chemicals 201

    Google Scholar 

  • OECD (1984b) Daphnia sp.,Acute immobilisation test and reproduction test. OECD Guidelines For Testing of Chemicals 202

    Google Scholar 

  • Pacifici R, Paris L, Di Carlo S, Pichini S, Zuccaro P (1991) Immunologic aspects of carbamazepine treatment in epileptic patients. Epilepsia 32 (1) 22–127

    Article  Google Scholar 

  • Pacifici R, Di Carlo S, Bacosi A, Pichini S, Zuccaro P (1992) Immunomodulating properties of carbamazepine in mice. Int J Immunopharmacol 14 (4): 605–611

    Article  CAS  Google Scholar 

  • Pfluger P, Prietz A, Wasserrab B, Koster C, Knörzer B, Dietrich DR (2000) Untersuchungen zur aquatischen Toxizität und zur endokrinen Aktivität von Carbamazepin. EUREGIO Ökotoxikologie Service Labor, Universität Konstanz, Konstanz

    Google Scholar 

  • Richardson ML, Bowron JM (1985) The fate of pharmaceutical chemicals in the environment. J Pharm Pharmacol 37: 1–12

    Article  CAS  Google Scholar 

  • Rittmannsberger H (1990) Carbamazepine in the treatment of psychiatric diseases: effects and side effects. Wien Med Wochenschr 140(15)398–404

    Google Scholar 

  • Rote Liste (2000) Bundesverband der pharmazeutischen Industrie e.V.

    Google Scholar 

  • Safe SH (1992) Development, validation and limitations of toxic equivalent factors. Chemosphere 25 (1–2): 61–64

    Article  CAS  Google Scholar 

  • Safe SH (1998) Hazard and risk assessment of chemical mixtures using the toxic equivalency factor approach. Environ Health Perspect so6(Suppl 4)x051–1o58

    Google Scholar 

  • Schwabe U, Paffrath D (1996) Arzneiverordnungsreport ‘86. Aktuelle Daten, Kosten, Trends und Kommentare. Gustav Fischer Verlag, Stuttgart, Jena (Drug prescription report 96 current data, costs, trends and comments)

    Google Scholar 

  • Stan HJ, Heberer T, Linkerhägner M (1994) Vorkommen von Clofibrinsäure im aquatischen System–Führt die therapeutische Anwendung zu einer Belastung von Oberflächen-, Grund-und Trinkwasser? Vom Wasser 83: 57–68

    CAS  Google Scholar 

  • Stuer-Lauridsen F, Birkved M, Hansen LP, Lützhwft H, Halling-Sorensen B (2000) Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40: 783–793

    Article  CAS  Google Scholar 

  • Stumpf M, Ternes TA, Haberer K, Baumann W (1996a) Nachweis von natürlichen und synthetischen

    Google Scholar 

  • Östrogenen in Kläranlagen und Fliessgewässern. Vom Wasser 87:251–261

    Google Scholar 

  • Stumpf M, Ternes TA, Haberer K, Seel P, Baumann W (1996b) Nachweis von Arzneimittelrückständen in Kläranlagen und Fließgewässern. Vom Wasser 86: 291–303

    CAS  Google Scholar 

  • Tafalla C, Novoa B, Alvarez JM, Figueras A (1999) In vivo and in vitro effect of oxytetracycline treatment on the immune response of turbot, Scophthalmus maximus (L). J Fish Dis 22 (4): 271–276

    Article  CAS  Google Scholar 

  • Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Wat Res 32 (n): 3245–3260

    Article  CAS  Google Scholar 

  • Ternes TA, Hirsch R, Mueller J, Haberer K (1998) Methods for the determination of neutral drugs as well as betablockers and beta2-sympathomimetics in aqueous matrices using GC/MS and LC/MS/MS. Fresenius J Anal Chem 362 (3): 329–340

    Article  CAS  Google Scholar 

  • Ternes TA, Hirsch RW, Stumpf M, Eggert T, Schuppert BF, Haberer K (1999a) Nachweis und Screening von Arzneimittelrückständen, Diagnostika und Antiseptika in der aquatischen Umwelt. ESWEInstitut für Wasserforschung und Wassertechnologie GmbH, Wiesbaden

    Google Scholar 

  • Ternes TA, Stumpf M, Müller J, Haberer K, Wilken RD, Servos M (1999b) Behaviour and occurrence of estrogens in municipal sewage treatment plants. I. Investigations in Germany, Canada and Brazil. Sci Total Environ 225: 81–90

    Google Scholar 

Download references

Authors
  1. P. Pfluger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. R. Dietrich
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Umweltmedizin und Krankenhaushygiene, Universitätsklinikum Freiburg, Hugstetter Straße 55, D-79106, Freiburg i. Br., Germany

    Klaus Kümmerer

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pfluger, P., Dietrich, D.R. (2001). Effects on Pharmaceuticals in the Environment — an Overview and Principle Considerations. In: Kümmerer, K. (eds) Pharmaceuticals in the Environment. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04634-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-04634-0_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-04636-4

  • Online ISBN: 978-3-662-04634-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation